Pictet Asset Management
OLMA icon

Pictet Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Pictet Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-217,023
Closed -$3.24M – 2187
2026
Q1 		$3.24M Sell
217,023
-285,545
-57% -$6.36M ﹤0.01% 831
2025
Q4 		$12.6M Sell
502,568
-1,133,804
-69% -$20.2M 0.01% 623
2025
Q3 		$16M Sell
1,636,372
-242,641
-13% -$1.46M 0.02% 571
2025
Q2 		$8M Hold
1,879,013
– – 0.01% 698
2025
Q1 		$7.07M Sell
1,879,013
-4,341
-0.2% -$21.8K 0.01% 739
2024
Q4 		$11M Buy
1,883,354
+215,895
+13% +$2.16M 0.01% 641
2024
Q3 		$19.9M Buy
+1,667,459
New +$21.3M 0.02% 495

Other funds holding OLMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

Pictet Asset Management's OLMA Position: Q2 2026 in Review

Pictet Asset Management sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 217,023 shares — an estimated $3.24M sold.

Pictet Asset Management first reported a position in OLMA in Q3 2024 and held it in 7 quarters. The position peaked at $19.9M in Q3 2024. 70 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Pictet Asset Management reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Pictet Asset Management sold 217,023 Olema Pharmaceuticals shares in Q2 2026, an estimated $3.24M.
  • Pictet Asset Management first reported a position in Olema Pharmaceuticals in Q3 2024 and held it in 7 quarters.
  • Pictet Asset Management's Olema Pharmaceuticals position peaked at $19.9M in Q3 2024.
  • 70 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.